Tempest Therapeutics, Inc. Restricted Cash and Cash Equivalents
Tempest Therapeutics, Inc. (TPST) had Restricted Cash and Cash Equivalents of $32.71 million as of 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2018-11-09
- 2018-09-30: Restricted Cash and Cash Equivalents $32.71M.
- 2018-06-30: Restricted Cash and Cash Equivalents $25.39M.
- 2018-03-31: Restricted Cash and Cash Equivalents $20.51M.
- 2017-12-31: Restricted Cash and Cash Equivalents $16.49M.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2018-09-30 | $32.71M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $25.39M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $20.51M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $16.49M 10-Q · filed 2018-11-09 |
| 2017-09-30 | $25.56M 10-Q · filed 2018-11-09 |
| 2017-06-30 | $23.75M 10-Q · filed 2018-08-09 |
| 2017-03-31 | $25.87M 10-Q · filed 2018-05-03 |
| 2016-12-31 | $44.37M 10-Q · filed 2018-11-09 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-03 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-04 |
| 2016-03-31 | $109.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $197.00K 10-Q · filed 2016-11-03 |
| 2015-09-30 | $109.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $109.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $109.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $0.00 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |